Page last updated: 2024-10-28

phenelzine and Cognition Disorders

phenelzine has been researched along with Cognition Disorders in 3 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graham, PM1
Potter, JM1
Paterson, J1
Georgotas, A1
McCue, RE1
Reisberg, B1
Ferris, SH1
Nagachandran, N1
Chang, I1
Mir, P1
Raskin, A1

Trials

1 trial available for phenelzine and Cognition Disorders

ArticleYear
The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients.
    International psychogeriatrics, 1989,Fall, Volume: 1, Issue:2

    Topics: Affect; Aged; Aged, 80 and over; Cognition Disorders; Depressive Disorder; Double-Blind Method; Fema

1989

Other Studies

2 other studies available for phenelzine and Cognition Disorders

ArticleYear
Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction.
    Lancet (London, England), 1982, Aug-21, Volume: 2, Issue:8295

    Topics: Adolescent; Anorexia Nervosa; Cognition Disorders; Confusion; Drug Interactions; Female; Fever; Huma

1982
Age-sex differences in response to antidepressant drugs.
    The Journal of nervous and mental disease, 1974, Volume: 159, Issue:2

    Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro

1974